FDG PET/CT of the non-malignant liver in an increasingly obese world population.

Keramida, Georgia; Peters, A Michael

Keramida, Georgia; Peters, A Michael.

Affiliation

Keramida G; Department of Nuclear Medicine, Royal Brompton and Harefield, NHS Foundation Trust, London, UK.
Peters AM; Department of Nuclear Medicine, King's College Hospital, NHS Foundation Trusts, London, UK.

Clin Physiol Funct Imaging ; 40(5): 304-319, 2020 Sep.

Article in En | MEDLINE | ID: mdl-32529712

Subject(s)

Fluorodeoxyglucose F18; Non-alcoholic Fatty Liver Disease; Humans; Liver/diagnostic imaging; Non-alcoholic Fatty Liver Disease/diagnostic imaging; Obesity; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography; Radiopharmaceuticals

Key words

F-18-fluorodeoxyglucose; glucose metabolism; liver; positron emission tomography

Fulltext

XML

PubMed Links

Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Fluorodeoxyglucose F18 / Non-alcoholic Fatty Liver Disease Type of study: Prognostic_studies Limits: Humans Language: En Journal: Clin Physiol Funct Imaging Journal subject: FISIOLOGIA / PATOLOGIA Year: 2020 Type: Article Affiliation country: United kingdom

Fulltext

XML

PubMed Links

Search on Google